From HPO
Joint hemorrhage- MedGen UID:
- 5479
- •Concept ID:
- C0018924
- •
- Pathologic Function
Hemorrhage occurring within a joint.
Intracranial hemorrhage- MedGen UID:
- 101799
- •Concept ID:
- C0151699
- •
- Pathologic Function
Hemorrhage occurring within the skull.
Epistaxis- MedGen UID:
- 4996
- •Concept ID:
- C0014591
- •
- Pathologic Function
Epistaxis, or nosebleed, refers to a hemorrhage localized in the nose.
Gingival bleeding- MedGen UID:
- 42218
- •Concept ID:
- C0017565
- •
- Pathologic Function
Hemorrhage affecting the gingiva.
Menorrhagia- MedGen UID:
- 44358
- •Concept ID:
- C0025323
- •
- Pathologic Function
Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.
Prolonged partial thromboplastin time- MedGen UID:
- 66815
- •Concept ID:
- C0240671
- •
- Finding
Increased time to coagulation in the partial thromboplastin time (PTT) test, a measure of the intrinsic and common coagulation pathways. Phospholipid, and activator, and calcium are mixed into an anticoagulated plasma sample, and the time is measured until a thrombus forms.
Prolonged prothrombin time- MedGen UID:
- 208879
- •Concept ID:
- C0853225
- •
- Finding
Increased time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula
Prolonged bleeding after surgery- MedGen UID:
- 867284
- •Concept ID:
- C4021646
- •
- Pathologic Function
Bleeding that persists longer than the normal time following a surgical procedure.
Reduced factor X activity- MedGen UID:
- 892449
- •Concept ID:
- C4024702
- •
- Finding
Reduced activity of coagulation factor X. The extrinsic and intrinsic pathways converge at factor X (fX). The extrinsic pathway activates fX by means of d factor VII with its cofactor, tissue factor. The intrinsic pathway activates fX by means of the tenase complex (Ca2+ and factors VIIIa, IXa and X) on the surface of activated platelets. Factor Xa in turn activates prothrombin (factor II) to thrombin (factor IIa).
Intramuscular hematoma- MedGen UID:
- 777032
- •Concept ID:
- C0240412
- •
- Finding
Blood clot formed within muscle tissue following leakage of blood into the tissue.
- Abnormality of blood and blood-forming tissues
- Abnormality of the cardiovascular system
- Abnormality of the musculoskeletal system